PhoenixBio Co., Ltd. 6190.T Stock
PhoenixBio Co., Ltd. Price Chart
PhoenixBio Co., Ltd. 6190.T Financial and Trading Overview
| PhoenixBio Co., Ltd. stock price | 473 JPY |
| Previous Close | 570 JPY |
| Open | 567 JPY |
| Bid | 567 JPY x 0 |
| Ask | 574 JPY x 0 |
| Day's Range | 567 - 575 JPY |
| 52 Week Range | 534 - 834 JPY |
| Volume | 17.7K JPY |
| Avg. Volume | 17.54K JPY |
| Market Cap | 1.92B JPY |
| Beta (5Y Monthly) | 0.652107 |
| PE Ratio (TTM) | 60.25505 |
| EPS (TTM) | 23.09 JPY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6190.T Valuation Measures
| Enterprise Value | 1.65B JPY |
| Trailing P/E | 60.25505 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.9040954 |
| Price/Book (mrq) | 1.3608643 |
| Enterprise Value/Revenue | 0.775 |
| Enterprise Value/EBITDA | 3.093 |
Trading Information
PhoenixBio Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.652107 |
| 52-Week Change | -2.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 834 JPY |
| 52 Week Low | 534 JPY |
| 50-Day Moving Average | 575.96 JPY |
| 200-Day Moving Average | 645.34 JPY |
6190.T Share Statistics
| Avg. Volume (3 month) | 17.54K JPY |
| Avg. Daily Volume (10-Days) | 33.96K JPY |
| Shares Outstanding | 3.39M |
| Float | 1.35M |
| Short Ratio | N/A |
| % Held by Insiders | 53.00% |
| % Held by Institutions | 10.00% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 23.21% |
| Operating Margin (ttm) | 23.96% |
| Gross Margin | 73.30% |
| EBITDA Margin | 25.04% |
Management Effectiveness
| Return on Assets (ttm) | 12.00% |
| Return on Equity (ttm) | 42.10% |
Income Statement
| Revenue (ttm) | 2.12B JPY |
| Revenue Per Share (ttm) | 625.28 JPY |
| Quarterly Revenue Growth (yoy) | 18.69% |
| Gross Profit (ttm) | N/A |
| EBITDA | 532M JPY |
| Net Income Avi to Common (ttm) | 493M JPY |
| Diluted EPS (ttm) | 9.41 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.56B JPY |
| Total Cash Per Share (mrq) | 427.93 JPY |
| Total Debt (mrq) | 1.13B JPY |
| Total Debt/Equity (mrq) | 74.57 JPY |
| Current Ratio (mrq) | 1.782 |
| Book Value Per Share (mrq) | 416.647 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 277M JPY |
| Levered Free Cash Flow (ttm) | 82.25M JPY |
Profile of PhoenixBio Co., Ltd.
| Country | Japan |
| State | N/A |
| City | Higashihiroshima |
| Address | 3-4-1 Kagamiyama |
| ZIP | 739-0046 |
| Phone | 81 8 2431 0016 |
| Website | https://www.phoenixbio.co.jp |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
PhoenixBio Co., Ltd. provides contract study services for drug discovery and development primarily in Japan. The company uses PXB-mouse, a chimeric mouse with a humanized liver for use in drug development experiments. Its contract study services in the field of drug discovery and development includes DMPK studies; safety studies; viral hepatitis-related studies; efficacy and safety studies for human specific nucleic acids, antibody, or polypeptide medicines; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
Q&A For PhoenixBio Co., Ltd. Stock
What is a current 6190.T stock price?
PhoenixBio Co., Ltd. 6190.T stock price today per share is 473 JPY.
How to purchase PhoenixBio Co., Ltd. stock?
You can buy 6190.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PhoenixBio Co., Ltd.?
The stock symbol or ticker of PhoenixBio Co., Ltd. is 6190.T.
Which industry does the PhoenixBio Co., Ltd. company belong to?
The PhoenixBio Co., Ltd. industry is Biotechnology.
How many shares does PhoenixBio Co., Ltd. have in circulation?
The max supply of PhoenixBio Co., Ltd. shares is 4.03M.
What is PhoenixBio Co., Ltd. Price to Earnings Ratio (PE Ratio)?
PhoenixBio Co., Ltd. PE Ratio is 20.48505800 now.
What was PhoenixBio Co., Ltd. earnings per share over the trailing 12 months (TTM)?
PhoenixBio Co., Ltd. EPS is 23.09 JPY over the trailing 12 months.
Which sector does the PhoenixBio Co., Ltd. company belong to?
The PhoenixBio Co., Ltd. sector is Healthcare.